Lianhua Zhu

Lianhua Zhu

Auto-generated profile, based on publicly available information

Lianhua Zhu

Department of Ultrasound, the First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Rd, Haidian District, Beijing 100853, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2024 in Bioengineering & Translational Medicine
Verified
Journal Article
Open access
LRLing Ren
Ling Ren
YZYuzhuo Zhao
Yuzhuo Zhao
TWTiantian Wang
Tiantian Wang
YTYan Tong
Yan Tong
PZPing Zhao
Ping Zhao
LZLianhua Zhu
Lianhua Zhu
Background: Microcirculatory perfusion disorder and inflammatory response are critical links in acute kidney injury (AKI). We aim to construct anti‐vascular cell adhesion molecule‐1(VCAM‐1) targeted microbubbles (TM) to monitor renal microcirculatory perfusion and inflammatory response.Methods: TM carrying VCAM‐1 polypeptide was constructed by biological coupling. The binding ability of TM to human umbilical vein endothelial cells (HUVECs) was detected. Bilateral renal ischemia–reperfusion injury (IRI) models of mice were established to evaluate microcirculatory perfusion and inflammatory response using TM. Thirty‐six mice were randomly divided into six groups according to the different reperfusion time (0.5, 2, 6, 12, and 24 h) and sham‐operated group (Sham group). The correlation of TM imaging with serum and histopathological biomarkers was investigated.Results: TM has advantages such as uniform distribution, regular shape, high stability, and good biosafety. TM could bind specifically to VCAM‐1 molecule expressed by tumor necrosis factor‐alpha (TNF‐α)‐treated HUVECs. In the renal IRI‐AKI model, the area under the curve (AUC) of TM significantly decreased both in the renal cortical and medullary after 2 h of reperfusion compared with the Sham group (p < 0.05). Normalized intensity difference (NID) of TM at different reperfusion time was all higher than that of blank microbubbles (BM) and the Sham group (p < 0.05). Ultrasound molecular imaging of TM could detect AKI early before commonly used renal function markers, histopathological biomarkers, and BM imaging. AUC of TM was negatively correlated with serum creatinine (Scr), blood urea nitrogen (BUN), and Cystatin C (Cys‐C) levels, and NID of TM was linearly correlated with VCAM‐1, TNF‐α, and interleukin‐6 (IL‐6) expression (p < 0.05).Conclusions: Ultrasound molecular imaging based on TM carrying VCAM‐1 polypeptide can accurately evaluate the changes in renal microcirculatory perfusion and inflammatory response, which might be a promising modality for early diagnosis of AKI.

2 November 2021 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JBJiang Bo
Jiang Bo
HPHan Peng
Han Peng
ZLZhu LianHua
Zhu LianHua
FXFei Xiang
Fei Xiang
YLYukun Luo
Yukun Luo
Transarterial chemoembolization (TACE) is an effective locoregional therapy in hepatocellular carcinoma (HCC). However, it is difficult to predict the tumour response (TR) of TACE intraprocedurally. The aim of this study was to predict the TR after TACE (1–3 months) in HCC patients using intraprocedural intraarterial contrast enhanced ultrasound (IA-CEUS). In this case-control study, consecutive patients who received TACE in our hospital from September 2018 to May 2019 were enrolled. IA-CEUS was performed before and after TACE. Postoperative contrast-enhanced liver MRI was performed 1–3 months after TACE as the gold standard. According to the modified Response Evaluation Criteria in Solid Tumours (mRECIST), ultrasonic manifestations were compared between the complete remission (CR) group and non-CR group by univariate and multivariate analyses. A logistic predictive model was established and validated, and its diagnostic efficiency was evaluated. Forty-four patients with sixty-one lesions were enrolled in the study. Multivariate analysis identified, the risk factors as a large lesion diameter (OR: 1.84; 95% confidence interval [CI]: 1.009, 3.080; P = 0.020), a larger dimension of non-enhancing area in superior mesenteric artery (SMA)-CEUS than the size in B-mode ultrasound preoperatively (OR: 3.379; 95% CI: 1.346,8.484; P = 0.010), presence of corona enhancement in hepatic artery (HA)-CEUS postoperatively (OR: 6.642; 95% CI: 1.214, 36.331; P = 0.029), and decreased corona enhancement thickness (per centimetre) postoperatively (OR: 0.025; 95% CI: 0.006,0.718; P = 0.025). The area under the receiver operating characteristic curve (AUROC) of the predictive model was 0.904 (95% CI: 0.804, 0.966; P < 0.001). The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were 81.08, 91.67, 85.25, 93.75, and 75.86%, respectively. Leave-one-out cross-validation (LOOCV) showed that the accuracy was 77.05%. Intraprocedural IA-CEUS can be used to predict the TR in HCC patients after TACE.

5 February 2024 in European Journal of Pharmacology
Verified
Journal Article
Closed access
LRLing Ren
Ling Ren
YZYuzhuo Zhao
Yuzhuo Zhao
XJXianpu Ji
Xianpu Ji
WLWenqing Li
Wenqing Li
WJWenli Jiang
Wenli Jiang
YLYukun Luo
Yukun Luo

10 September 2024 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
XFXiang Fei
Xiang Fei
ZCZhihao Cheng
Zhihao Cheng
LZLianhua Zhu
Lianhua Zhu
PHPeng Han
Peng Han
NLNan Li
Nan Li
WLWenping Lv
Wenping Lv


1 December 2025 in Radiology
Verified
Journal Article
Closed access
LZLianhua Zhu
Lianhua Zhu
BJBo Jiang
Bo Jiang
XFXiang Fei
Xiang Fei
YXYinzhe Xu
Yinzhe Xu
ZLZhe Liu
Zhe Liu
YLYukun Luo
Yukun Luo
Contrast-enhanced US demonstrated a sensitivity and area under the receiver operating characteristic curve noninferior to contrast-enhanced MRI in the detection of residual hepatocellular carcinoma after lenvatinib and anti–programmed cell death protein-1 antibody therapy.